Director, Interventional Cardiology and Cardiac Cath Labs
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Howard C. Herrmann, MD, is the John Bryfogle Professor of Medicine and Surgery at the Perelman School of Medicine of the University of Pennsylvania, Health System Director for Interventional Cardiology, and Director of the Catheterization Labs at the Hospital of the University of Pennsylvania. He graduated from Harvard College, Harvard Medical School, and completed his training at Massachusetts General Hospital. Dr.Herrmann has authored or coauthored more than 400 articles with a current research focus on valvular and structural heart disease. He serves on multiple editorial boards and is Deputy Editor of NEJM Journal Watch Cardiology. He is a past Governor of the PA Chapter of the ACC and received the Master Designation and serves on the Board of Trustees of SCAI. He has been consistently listed in Philadelphia Magazine’s Top Docs, Best Doctors in America, and the Guide to America’s Top Doctors.
Saturday, February 25, 2023
4:45 PM – 4:55 PM ET
Disclosure information not submitted.
Sunday, February 26, 2023
8:00 AM – 9:45 AM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Sunday, February 26, 2023
9:04 AM – 9:45 AM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Sunday, February 26, 2023
11:21 AM – 11:29 AM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Sunday, February 26, 2023
11:37 AM – 12:00 PM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Monday, February 27, 2023
8:00 AM – 8:55 AM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Monday, February 27, 2023
8:55 AM – 9:40 AM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Monday, February 27, 2023
11:30 AM – 12:30 PM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Monday, February 27, 2023
3:52 PM – 5:45 PM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Monday, February 27, 2023
5:20 PM – 5:45 PM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Monday, February 27, 2023
2:40 PM – 3:15 PM ET
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)